HIV :: FDA approves antiretroviral drug Maraviroc for HIV patients

The U.S. Food and Drug Administration (FDA) approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA.

ADHD :: Gene variant is associated with brain anatomy, clinical course of ADHD

A variant of the dopamine receptor gene may be associated with attention-deficit/hyperactivity disorder (ADHD) and with thinner tissue in areas of the brain that handle attention, but also appears associated with better clinical outcomes among individuals with the disorder, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Coffee & caffeine may protect memory in older women

Drinking more than three cups of coffee (or the equivalent in tea) per day or caffeine may help older women protect their thinking skills, according to a study published in the August 7, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

Melanoma :: Research shows incidence of melanoma on the rise

Over the past several decades, the incidence of melanoma ? the most serious form of skin cancer ? has steadily increased in the United States. From 1995 to 2004, melanoma has increased by more than 1 percent per year in this country ? in sharp contrast to overall cancer rates that have steadily decreased by 0.6 percent per year during this time.

Skin :: New technologies tighten skin from head to toe without surgery

If sagging skin is getting you down, recent advances in skin-tightening technologies can lift your spirits ? and your skin ? in a matter of a few office visits to your dermatologist. The beauty of these non-invasive procedures is their ability to treat loose skin virtually anywhere on the body without the risks and downtime associated with surgery.

Heart Failure :: Novel candidate biomarker for heart failure also strongly predicts risk of death

A potential new biomarker for heart failure may be more powerful than established measures in identifying patients at increased risk for death from several causes. In a report to appear in the Journal of the American College of Cardiology that has received early online release, an international research team describes finding that blood levels of a protein called ST2 both indicate the presence of heart failure among patient with shortness of breath and powerfully predict the risk that a patient will die during the following year.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack